| Scrip Code | 544293 |
|---|---|
| NSE Symbol | SURAKSHA |
| MSEI Symbol | NOTLISTED |
| ISIN | INE877V01027 |
| Name of company | SURAKSHA DIAGNOSTIC LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 05-02-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 27-01-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Third quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | DIAGNOSTIC |
| Start date and time of board meeting | 05-02-2026 15:00:00 |
| End date and time of board meeting | 05-02-2026 16:25:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 7,558.09 | 22,212.32 | |
| Other income | 98.66 | 304.95 | |
| Total income | 7,656.75 | 22,517.27 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 857.65 | 2,606.83 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0.00 | 0.00 |
| (d) | Employee benefit expense | 1,303.31 | 3,843.77 |
| (e) | Finance costs | 309.86 | 847.47 |
| (f) | Depreciation, depletion and amortisation expense | 1,010.88 | 2,891.59 |
| (f) | Other Expenses | ||
| 1 | Impairment Loss | 85.85 | 17.26 |
| 2 | Advertisement | 189.97 | 383.70 |
| 3 | Rent Expenses | 121.97 | 391.91 |
| 4 | Power and fuel | 235.53 | 709.17 |
| 5 | Professional fees paid | 1,312.38 | 3,813.14 |
| 6 | Repairs and maintenance | 239.96 | 700.73 |
| 7 | Information technology expenses | 104.74 | 352.17 |
| 8 | Security and housekeeping charges | 189.49 | 542.32 |
| 9 | Commission to collection centre | 138.79 | 402.68 |
| 10 | Other Expenses | 459.61 | 1,348.74 |
| Total other expenses | 3,078.29 | 8,661.82 | |
| Total expenses | 6,559.99 | 18,851.48 | |
| 3 | Total profit before exceptional items and tax | 1,096.76 | 3,665.79 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | 1,096.76 | 3,665.79 |
| 6 | Tax expense | ||
| 7 | Current tax | 239.35 | 833.51 |
| 8 | Deferred tax | 43.35 | 96.98 |
| 9 | Total tax expenses | 282.70 | 930.49 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 814.06 | 2,735.30 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 814.06 | 2,735.30 |
| 17 | Other comprehensive income net of taxes | 9.52 | 28.56 |
| 18 | Total Comprehensive Income for the period | 823.58 | 2,763.86 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 0.00 | 0.00 | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 0.00 | 0.00 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0.00 | 0.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 1,041.62 | 1,041.62 | |
| Face value of equity share capital | 2 | 2 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 1.56 | 5.25 | |
| Diluted earnings (loss) per share from continuing operations | 1.56 | 5.25 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 1.56 | 5.25 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 1.56 | 5.25 | |
| 24 | Debt equity ratio | 0 | 0 |
| 25 | Debt service coverage ratio | 0 | 0 |
| 26 | Interest service coverage ratio | 0 | 0 |
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Notes to the unaudited standalone financial results 1. The unaudited standalone financial results for the quarter and nine months ended 31 December 2025 of Suraksha Diagnostic Limited have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard Ind AS notified under Section 133 of the Companies Act 2013 as amended read with relevant rules thereunder and other accounting principles generally accepted in India and in accordance with Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015 as amended. 2. These unaudited standalone financial results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors in their respective meeting held on 05 February 2026. The statutory auditor have carried out limited review on these financial results and have issued an unmodified conclusion. 3. The Company is primarily engaged in the business of diagnostic centres for carrying out various pathology and radiology services and as such there are no separate reportable segments as per Ind AS 108 Operating Segments. 4. On 21 November 2025 the Government of India notified four Labour Codes - the Code on Wages 2019 the Industrial Relations Code 2020 the Code on Social Security 2020 and the Occupational Safety, Health and Working Conditions Code 2020 collectively referred to as the New Labour Codes. The Ministry of Labour and Employment published draft Central Rules and FAQs to enable assessment of the financial impact due to changes in regulations under the New Labour Codes. The Company has assessed and the incremental impact of these changes on the basis of the best information available for the period ended 31 December 2025 is not material to these financial results. The Management also continues to monitor the finalisation of Central or State Rules and clarifications from the Government on other aspects of the New Labour Code and would provide appropriate accounting effect on the basis of such developments as needed. 5. In a step down subsidiary of the Company an ongoing dispute with the Government of Meghalaya the public partner has resulted in operational losses. As a result the recoverability of the Company’s investments and loans advanced to subsidiary & trade receivables from step-down subsidiary, aggregating to Rs 345.56 lakhs as at 31 December 2025 is under assessment. Based on the legal opinion obtained and managements assessment the Company believes that the outcome of the on going proceedings will be in favour of the step-down subsidiary. Accordingly no provision has been considered necessary in respect of the aforesaid matter in the unaudited standalone financial results for the quarter and period ended 31 December 2025. 6. These unaudited consolidated financial results are also available on the Holding Companys website www.surakshanet.com and on the stock exchange websites www.bseindia.com and www.nseinda.com. 7. Previous periods or years figures have been regrouped or reclassified wherever necessary to conform to current periods or years classification. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-10-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 31-12-2025 | 31-12-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement gain/(loss) of net defined benefit plan | 12.72 | 38.16 |
| 2 | Income tax effect on above | (3.20) | (9.60) |
| Total Amount of items that will not be reclassified to profit and loss | 9.52 | 28.56 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 0.00 | 0.00 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | 9.52 | 28.56 |
| Whether results are audited or unaudited | Unaudited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | MSKA & Associates LLP | Yes | 31-07-2027 | ||
|---|---|---|---|---|---|